Glancy Prongay Wolke & Rotter Investigates Enovix After 28.66% Share Price Drop

Glancy Prongay Wolke & Rotter LLP announced a securities fraud investigation into Enovix Corporation on November 13, 2026, after the battery maker's shares fell 28.66% on November 12, 2026. Business Wire published the firm's announcement, which states that no lawsuit has been filed.

Enovix Guidance and the Glancy Investigation

Enovix reported third quarter 2026 results on November 12, 2026, and issued fourth quarter revenue guidance of $9 million to $10 million, below the $13.18 million analyst consensus cited by Zacks. The company said its 2027 revenue outlook of $65 million to $85 million assumes little to no smartphone revenue as it prioritizes drone, defense and smart-eyewear applications. Enovix shares fell $0.73, or 28.66%, to close at $1.81 on November 12, 2026.

Glancy Prongay Wolke & Rotter LLP is reviewing whether Enovix or its executives may have made false or misleading statements to investors in violation of federal securities laws. "Investors who suffered losses deserve to know whether they were given complete and accurate information prior to the disclosure, and our investigation seeks to answer that question," said Charles H. Linehan, a partner at the firm. Glancy represents investors on a contingency fee basis, with attorneys' fees and litigation expenses paid only from any recovery and subject to court approval. The firm said it was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.

Enovix's Battery Business and Balance Sheet

Enovix designs and manufactures 100% active silicon-anode lithium-ion batteries using a proprietary 3D architecture, selling directly to enterprise OEMs in smartphones, smart eyewear, drones, wearables and industrial markets, according to akta.pro company records. The same records show full-year 2025 revenue of $31.8 million, a 38% year-over-year increase, and a cash position of $582.7 million as of the first quarter of 2026. Enovix reported first quarter 2026 revenue of $7.6 million, up 49% year-over-year and above guidance, with a non-GAAP gross margin of 26.3%.

Enovix Leadership Changes Before the Decline

Enovix announced the surprise departure of CEO Raj Talluri in August 2026, which sent its stock to new all-time lows, Seeking Alpha reported. Arthi Chakravarthy, the company's Chief Legal Officer and Corporate Secretary, departed effective October 30, 2026, with no reason disclosed and no replacement named, according to TradingView. On October 22, 2026, Enovix said a $100 million 2027 revenue estimate in an article was not company-authorized guidance and that updated guidance was expected November 12, 2026, TradingView reported.

What Comes Next for Enovix Investors

Glancy is investigating potential claims on behalf of Enovix investors, and investors who lost money can contact the firm about the investigation. The firm's announcement states that if a securities class action is later filed against Enovix, investors may have the opportunity to seek appointment as lead plaintiff.